GRI BIO, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
GRI BIO, INC. (GRI) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $27.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-14
- GRI BIO, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $14.00K, a 16.67% increase year-over-year.
- GRI BIO, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $13.00K, a 18.18% increase year-over-year.
- GRI BIO, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $12.00K.
- GRI BIO, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $13.00K.
- GRI BIO, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $48.00K.
- GRI BIO, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $53.00K, a 12.77% increase from fiscal 2022.
- GRI BIO, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $47.00K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $27.00K 10-Q · filed 2026-08-14 | $39.00K derived: sum of 3 quarters · filed 2026-08-14 | $52.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $13.00K 10-Q · filed 2026-05-13 | $25.00K derived: sum of 2 quarters · filed 2026-05-13 | $38.00K derived: sum of 3 quarters · filed 2026-05-13 | $50.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-30 | $25.00K derived: sum of 2 quarters · filed 2026-01-30 | $37.00K derived: sum of 3 quarters · filed 2026-08-14 | $48.00K 10-K · filed 2026-01-30 |
| 2025-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $25.00K derived: sum of 2 quarters · filed 2026-08-14 | $36.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $23.00K 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | $11.00K 10-Q · filed 2026-05-13 | |||
| 2024-03-31 | $14.00K 10-Q · filed 2025-05-15 | $28.00K derived: sum of 2 quarters · filed 2025-05-15 | $41.00K derived: sum of 3 quarters · filed 2025-05-15 | $55.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $27.00K derived: sum of 2 quarters · filed 2025-03-14 | $41.00K derived: sum of 3 quarters · filed 2025-03-14 | $53.00K 10-K · filed 2025-03-14 |
| 2023-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $27.00K derived: sum of 2 quarters · filed 2024-11-14 | $39.00K 10-Q · filed 2024-11-14 | $51.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $26.00K 10-Q · filed 2024-08-14 | $38.00K derived: sum of 3 quarters · filed 2024-08-14 | $50.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $12.00K 10-Q · filed 2024-05-10 | $24.00K derived: sum of 2 quarters · filed 2024-05-10 | $36.00K derived: sum of 3 quarters · filed 2024-05-10 | |
| 2022-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $24.00K derived: sum of 2 quarters · filed 2024-03-28 | $47.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $35.00K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $23.00K 10-Q · filed 2023-08-14 |